UP1002 / UPPTHERA - LARVOL DELTA

N-Degron-Based PROTAC Targeting PLK1: A Potential Therapeutic Strategy for Cervical Cancer. (PubMed, Pharmaceutics) - "In vivo, NC1 suppressed tumor growth in a HeLa xenograft mouse model. This research highlights the potential of N-degron-based PROTACs targeting the PLK1 protein in cancer therapies, highlighting their potential in future cervical anticancer treatment strategies."

Journal • Cervical Cancer • Oncology • Solid Tumor • Targeted Protein Degradation • PLK1